Brief: Spago Nanomedical Q3 Loss Widens To SEK 10.1 Mln
Nov 10 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST :
* SPAGO NANOMEDICAL INTERIM REPORT JANUARY-SEPTEMBER 2021
* Q3 LOSS FOR QUARTER AMOUNTED TO KSEK -10,103 (KSEK
-4,485).
* Q3 NET SALES SEK 0.2 MILLION VERSUS SEK 67,000 YEAR AGO
Source text for Eikon: ID:nMFN6QB6Tt
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))